IDH1 and glioma: First, they started with fluorescence‐activated cell sorting (FACS) analysis (i.e., flow cytometry) of 10 IDH‐wildtype and six IDH‐mutant human glioma tissue samples, demonstrating fewer overall CD45+ immune cell infiltration.